Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) EPS (Basic) (2018 - 2025)

Avai Bio's EPS (Basic) history spans 6 years, with the latest figure at $0.01 for Q1 2024.

  • On a quarterly basis, EPS (Basic) rose 135.92% to $0.01 in Q1 2024 year-over-year; TTM through Mar 2024 was -$0.01, a 54.59% increase, with the full-year FY2025 number at -$0.01, up 50.0% from a year prior.
  • EPS (Basic) hit $0.01 in Q1 2024 for Avai Bio, up from -$0.01 in the prior quarter.
  • Over the last five years, EPS (Basic) for AVAI hit a ceiling of $0.02 in Q4 2020 and a floor of -$0.03 in Q1 2023.
  • Historically, EPS (Basic) has averaged -$0.0 across 4 years, with a median of $0.0 in 2020.
  • Biggest five-year swings in EPS (Basic): surged 882.96% in 2020 and later crashed 731.22% in 2023.
  • Tracing AVAI's EPS (Basic) over 4 years: stood at $0.02 in 2020, then crashed by 78.41% to $0.0 in 2022, then tumbled by 391.76% to -$0.01 in 2023, then soared by 200.0% to $0.01 in 2024.
  • Business Quant data shows EPS (Basic) for AVAI at $0.01 in Q1 2024, -$0.01 in Q4 2023, and -$0.01 in Q3 2023.